BSECompany Update3d ago · 5 Aug 2026, 04:06 pm

PFA

Biogen Pharmachem Industries Ltd · 531752

✦ AI SummaryRegulatory

Biogen Pharmachem Industries Ltd has informed that it does not have any unused funds from past public issues or placements, as per SEBI's Regulation 32(1) of the Listing Obligation and Disclosure Requirements.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

819c33ee-cb05-4ecc-bb2f-46faa840ce0a.pdf

pdf

Download →
View document text
BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED) Date.:05.08.2026 Department of Corporate Services BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 531752 Security ID: BIOGEN Dear Sir / Madam, Sub: Disclosure under Regulation 32(1) of SEBI (listing Obligation and Disclosure Requirements) Regulations, 2015 Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 30th June 2026, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You. Yours Faithfully, FOR, BIOGEN PHARMACHEM INDUSTRIES LIMITED KELASH BUNKAR WHOLETIME DIRECTOR Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001 E mail biogenpharmachem@gmail.com